Paul Christopher Williams - Mar 6, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 06:51 PM
Previous filing
Feb 22, 2024
Next filing
Mar 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Employee Stock Option (right to buy) Award $0 +211 K $0.00 211 K Mar 6, 2024 Common Stock 211 K $7.07 Direct F1
transaction CTKB Restricted Stock Units Award $0 +141 K $0.00 141 K Mar 6, 2024 Common Stock 141 K Direct F2, F3

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 6, 2024 and each month thereafter.
F2 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F3 The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.